XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.20.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2020
Share-based Payment Arrangement [Abstract] |
Stock-Based Compensation | Stock-Based Compensation We recognized total stock-based compensation expense in our Condensed Consolidated Statements of Operations as follows (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Cost of goods sold | $ | 744 |  |  | $ | 1,119 |  |  | $ | 2,168 |  |  | $ | 3,208 |
Research and development | 14,212 |  |  | 15,680 |  |  | 43,826 |  |  | 47,549 |
General and administrative | 8,711 |  |  | 8,081 |  |  | 25,255 |  |  | 24,030 |
Impairment of assets and other costs for terminated program | — |  |  | — |  |  | 1,025 |  |  | — |
Total stock-based compensation | $ | 23,667 |  |  | $ | 24,880 |  |  | $ | 72,274 |  |  | $ | 74,787 |
The stock-based compensation expense reported in impairment of assets and other costs for terminated program results from executive severance, which we accounted for as a liability award. Upon issuance of the award in the three months ended June 30, 2020, we reclassified the award into equity. We issued stock-based awards and resulting shares of our common stock as follows (shares in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Options granted | 233 |  |  | 131 |  |  | 282 |  |  | 246 |
Weighted-average grant-date fair value of options granted | $ | 11.64 |  |  | $ | 13.43 |  |  | $ | 11.68 |  |  | $ | 15.81 |
RSUs granted | 693 |  |  | 316 |  |  | 1,213 |  |  | 712 |
Weighted-average grant-date fair value of RSUs granted | $ | 21.56 |  |  | $ | 28.00 |  |  | $ | 21.04 |  |  | $ | 31.80 |
Shares issued under equity compensation plans | 584 |  |  | 820 |  |  | 2,889 |  |  | 2,256 |
On June 17, 2020, the Stockholders of Nektar approved an amendment to the Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of Common Stock authorized for issuance thereunder by 10,000,000 shares, and an amendment and restatement of the Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of Common Stock authorized for issuance under the plan by 1,000,000 shares.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration